Ensysce Biosciences, Inc. Profile Avatar - Palmy Investing

Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activate…

Biotechnology
US, La Jolla [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Ensysce Biosciences, Inc. has no acquisition track records yet.

M&A Deals · History

Ensysce Biosciences, Inc. has no acquisition track records yet.

End of ENSC's Analysis
CIK: - CUSIP: 293602108 ISIN: US2936024056 LEI: - UEI: -
Secondary Listings
ENSC has no secondary listings inside our databases.